Eric Sullivan

Insider Reports History

Location
Boston, MA
Signature
/s/ Margaret Siegel as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric Sullivan:

Company Role Class Num Shares Value Price $ Report Date Ownership
TCR2 THERAPEUTICS INC. Chief Financial Officer Restricted Stock Unit 0 01 Jun 2023 Direct
TCR2 THERAPEUTICS INC. Chief Financial Officer Stock Option (Right to Buy) 0 $0.7400 01 Jun 2023 Direct

Insider Reports Filed by Eric Sullivan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TCRR TCR2 THERAPEUTICS INC. 01 Jun 2023 3 $0 4 Chief Financial Officer 01 Jun 2023, 16:31
TCRR TCR2 THERAPEUTICS INC. 15 Dec 2022 2 $0 4 Chief Financial Officer 19 Dec 2022, 16:29
TCRR TCR2 THERAPEUTICS INC. 27 Jun 2022 1 $0 4 Chief Financial Officer 27 Jun 2022, 17:18
TCRR TCR2 THERAPEUTICS INC. 27 Jun 2022 0 $0 3 Chief Financial Officer 27 Jun 2022, 17:12